Jean-Pierre Sommadossi, Atea Pharmaceuticals CEO

Atea con­firms un­so­licit­ed cash pro­pos­al from Tang Cap­i­tal’s Con­cen­tra, the shell buy­ing Jounce Ther­a­peu­tics

Atea Phar­ma­ceu­ti­cals, which went pub­lic in the fall of 2020 with the hopes of treat­ing Covid-19 and oth­er in­fec­tious dis­eases but has since strug­gled …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.